Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Forst

Showing results (61-70 of 148) with videos related to

Pageof 15
Sort By:
Journal of Diabetes and Its Complications|May 4, 2005
Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetesThomas Forst, Senait Forst, Klaudia Strunk, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 31, 2022
Diabetes Mellitus and the HeartKatharina Schütt, Thomas Forst, Andreas L Birkenfeld, et al.
Diabetes Technology & Therapeutics|December 20, 2011
Accuracy evaluation of five blood glucose monitoring systems obtained from the pharmacy: a European multicenter study with 453 subjectsCornelius Tack, Harald Pohlmeier, Thomas Behnke, et al.
Diabetes & Vascular Disease Research|January 8, 2013
Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studiesThomas Forst, Markolf Hanefeld, Stephan Jacob, et al.
Metabolism: Clinical and Experimental|March 23, 2023
Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studiesSusanna Bianzano, Andrea Henrich, Lena Herich, et al.
Journal of Diabetes Science and Technology|June 2, 2010
Laboratory evaluation of a new lateral-flow-based point-of-care rapid test for assessment of chronic systemic inflammationRenate Siebenhaar, Petra B Mushholt, Thomas Forst, et al.
Journal of the American College of Cardiology|June 21, 2005
Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer studyAndreas Pfützner, Nikolaus Marx, Georg Lübben, et al.
British Journal of Clinical Pharmacology|December 27, 2023
Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug-drug interactionsSara Armani, Andreas Geier, Thomas Forst, et al.
Metabolism: Clinical and Experimental|December 6, 2005
Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepirideAndreas Pfützner, Thomas Schöndorf, Daniela Seidel, et al.
Journal of Diabetes Science and Technology|June 2, 2010
Assessment of the mixing efficiency of neutral protamine Hagedorn cartridgesPia Kaiser, Sebastian Maxeiner, Alexander Weise, et al.
Pageof 15

Showing results (61-70 of 148) with videos related to

Sort By:
Pageof 15
Journal of Diabetes and Its Complications|May 4, 2005
Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetesThomas Forst, Senait Forst, Klaudia Strunk, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 31, 2022
Diabetes Mellitus and the HeartKatharina Schütt, Thomas Forst, Andreas L Birkenfeld, et al.
Diabetes Technology & Therapeutics|December 20, 2011
Accuracy evaluation of five blood glucose monitoring systems obtained from the pharmacy: a European multicenter study with 453 subjectsCornelius Tack, Harald Pohlmeier, Thomas Behnke, et al.
Diabetes & Vascular Disease Research|January 8, 2013
Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studiesThomas Forst, Markolf Hanefeld, Stephan Jacob, et al.
Metabolism: Clinical and Experimental|March 23, 2023
Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studiesSusanna Bianzano, Andrea Henrich, Lena Herich, et al.
Journal of Diabetes Science and Technology|June 2, 2010
Laboratory evaluation of a new lateral-flow-based point-of-care rapid test for assessment of chronic systemic inflammationRenate Siebenhaar, Petra B Mushholt, Thomas Forst, et al.
Journal of the American College of Cardiology|June 21, 2005
Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer studyAndreas Pfützner, Nikolaus Marx, Georg Lübben, et al.
British Journal of Clinical Pharmacology|December 27, 2023
Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug-drug interactionsSara Armani, Andreas Geier, Thomas Forst, et al.
Metabolism: Clinical and Experimental|December 6, 2005
Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepirideAndreas Pfützner, Thomas Schöndorf, Daniela Seidel, et al.
Journal of Diabetes Science and Technology|June 2, 2010
Assessment of the mixing efficiency of neutral protamine Hagedorn cartridgesPia Kaiser, Sebastian Maxeiner, Alexander Weise, et al.
Pageof 15